Neuropace Statistics
NASDAQ: NPCEHealth CareMedical/Dental InstrumentsUSD
7.95-0.19 (-2.33%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Neuropace by the numbers
Neuropace has a market capitalization of $273.9 million based on 34.45M shares outstanding. With trailing EPS of $-0.56, Neuropace is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 36.8% below its 50-day average and 45.4% below its 200-day average.
Average daily trading volume is 270.76K shares, or about $2.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NPCE valuation vs. peer median
| Metric | NPCE | Peer median | Difference |
|---|---|---|---|
| Market cap | $273.89M | $251.14M | +9% |
| Avg. volume | 270.76K | 374.14K | -28% |
Peer median across 8 companies: TMCI, INFU, SSII, OFIX, OSUR, PROF, CLPT, EMBC.
Valuation
- Market cap
- $273.89M
- Price / sales (latest FY)
- 2.74
- EPS (TTM)
- $-0.56
- Shares outstanding
- 34.45M
Price and trading
- Previous close
- 8.14
- Open
- 7.97
- Day range
- 7.85 – 8.29
- 52-week range
- 5.46 – 19.60
- 52-week change
- -44.60%
- Beta
- —
- Volume
- 749.38K
- Average volume
- 270.76K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 273.89M
- Forward Pe
- -21.42
- Eps
- -0.56
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.60
- Week52 Low
- 5.46
- Avg Volume
- 270.76K
- Shares Outstanding
- 34.45M
- Ma50
- 12.57
- Ma200
- 14.57
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -59.44%
- Pct From52w Low
- 45.60%